146 related articles for article (PubMed ID: 27943238)
1. Combination therapy of infliximab and ciclosporin in the treatment of recalcitrant psoriasis: a case series.
Martinez-Mera C; Camarero-Mulas C; Sanz-Sánchez T; Daudén E
Br J Dermatol; 2017 Mar; 176(3):803-805. PubMed ID: 27943238
[No Abstract] [Full Text] [Related]
2. Use of infliximab in the treatment of psoriasis.
Lee MR; Cooper AJ
Australas J Dermatol; 2004 Aug; 45(3):193-5. PubMed ID: 15250904
[No Abstract] [Full Text] [Related]
3. Infliximab for the treatment of psoriasis in the U.K.: 9 years' experience of infusion reactions at a single centre.
Wee JS; Petrof G; Jackson K; Barker JN; Smith CH
Br J Dermatol; 2012 Aug; 167(2):411-6. PubMed ID: 22404545
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of recalcitrant palmoplantar pustular psoriasis with sequential use of infliximab and adalimumab.
Yawalkar N; Hunger RE
Dermatology; 2009; 218(1):79-83. PubMed ID: 18974629
[No Abstract] [Full Text] [Related]
5. Juvenile generalized pustular psoriasis with IL36RN mutation treated with short-term infliximab.
Pan J; Qiu L; Xiao T; Chen HD
Dermatol Ther; 2016 May; 29(3):164-7. PubMed ID: 26627198
[TBL] [Abstract][Full Text] [Related]
6. Sequential therapy in plaque psoriasis using the " Hit and Run " approach: infliximab followed by efalizumab.
Penz S; Pelletier F; Riou-Gotta MO; Puzenat E; Levang J; Mermet I; Humbert P; Aubin F
Int J Dermatol; 2012 Feb; 51(2):236-7. PubMed ID: 22250639
[No Abstract] [Full Text] [Related]
7. Pustular psoriasis of pregnancy treated with ciclosporin and high-dose prednisolone.
Edmonds EV; Morris SD; Short K; Bewley SJ; Eady RA
Clin Exp Dermatol; 2005 Nov; 30(6):709-10. PubMed ID: 16197395
[No Abstract] [Full Text] [Related]
8. A prospective randomized controlled trial comparing infliximab and etanercept in patients with moderate-to-severe chronic plaque-type psoriasis: the Psoriasis Infliximab vs. Etanercept Comparison Evaluation (PIECE) study.
de Vries AC; Thio HB; de Kort WJ; Opmeer BC; van der Stok HM; de Jong EM; Horvath B; Busschbach JJ; Nijsten TE; Spuls PI
Br J Dermatol; 2017 Mar; 176(3):624-633. PubMed ID: 27416891
[TBL] [Abstract][Full Text] [Related]
9. The objective Psoriasis Area and Severity Index: a randomized controlled pilot study comparing the effectiveness of ciclosporin and methotrexate.
Choi CW; Kim BR; Seo E; Youn SW
Br J Dermatol; 2017 Dec; 177(6):1740-1741. PubMed ID: 28129675
[No Abstract] [Full Text] [Related]
10. Long-term durability and dose escalation patterns in infliximab therapy for psoriasis.
Luber AJ; Tsui CL; Heinecke GM; Lebwohl MG; Levitt JO
J Am Acad Dermatol; 2014 Mar; 70(3):525-32. PubMed ID: 24388425
[TBL] [Abstract][Full Text] [Related]
11. Long-term management of generalized pustular psoriasis with infliximab: case series.
Routhouska SB; Sheth PB; Korman NJ
J Cutan Med Surg; 2008; 12(4):184-8. PubMed ID: 18627699
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of methotrexate and cyclosporine in the treatment of psoriasis.
Bigby M
Arch Dermatol; 2004 Mar; 140(3):347-8. PubMed ID: 15023778
[No Abstract] [Full Text] [Related]
13. Successful treatment of severe recalcitrant psoriasis with combination infliximab and methotrexate.
Kirby B; Marsland AM; Carmichael AJ; Griffiths CE
Clin Exp Dermatol; 2001 Jan; 26(1):27-9. PubMed ID: 11260172
[TBL] [Abstract][Full Text] [Related]
14. Combination low-dose cyclosporin (Neoral) and hydroxyurea for severe recalcitrant psoriasis.
Kirby B; Harrison PV
Br J Dermatol; 1999 Jan; 140(1):186-7. PubMed ID: 10215804
[No Abstract] [Full Text] [Related]
15. Striking and rapid improvement of plaque psoriasis with infliximab. A report of two cases.
Al-Salem IH
Dermatology; 2003; 207(1):54-6. PubMed ID: 12835550
[TBL] [Abstract][Full Text] [Related]
16. Infliximab-induced remission of extensive plaque psoriasis.
Amital H; Ingber A; Rubinow A
Isr Med Assoc J; 2003 Nov; 5(11):827-8. PubMed ID: 14650114
[No Abstract] [Full Text] [Related]
17. Serum infliximab concentrations and disease activity: a descriptive study of patients with psoriasis.
Dannepond C; Ternant D; Maruani A; Machet L; Paintaud G; Samimi M
Br J Dermatol; 2016 Jan; 174(1):198-200. PubMed ID: 25864703
[No Abstract] [Full Text] [Related]
18. Re-induction as a possible alternative modality of dose escalation of infliximab: a prospective evaluation in a small series of psoriatic patients.
Cassano N; Puglisi Guerra A; Malara C; Loconsole F; Galluccio A; Pezza M; Vena GA
Int J Immunopathol Pharmacol; 2007; 20(3):647-50. PubMed ID: 17880779
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of treatment with infliximab in patients with moderate-severe psoriasis and high needs of therapy. A retrospective study of 43 patients].
Puig L
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():30-5. PubMed ID: 19080989
[TBL] [Abstract][Full Text] [Related]
20. A dramatic response to a single dose of infliximab in a patient with prolonged pustular psoriasis derived from inverse psoriasis.
Li M; Dai W; Yan W; Liu Y; Wang L; Li W
Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28419647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
